Submitted by Anonymous (not verified) on 18 August 2026 - 16:40
Human medicines European public assessment report (EPAR): Arixtra, fondaparinux sodium, Date of authorisation: 20/03/2002, Revision: 40, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Arixtra, fondaparinux sodium, Date of authorisation: 20/03/2002, Revision: 40, Status: Authorised